Cameco (CCJ) Earnings Analysis
Cameco (CCJ) next reports earnings on 2026-07-31, consensus EPS 0.31 USD. Last quarter (2026-02-13) it beat with EPS 0.36 USD vs 0.29 USD est (+24.1%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E 84.89.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CCJ next report earnings?
| Next earnings date | 2026-07-31 |
|---|---|
| Consensus EPS estimate | 0.31 USD |
| Revenue estimate | 0.57B |
CCJ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-13 | 0.36 USD | 0.29 USD | +24.1% | Beat |
| 2025-07-31 | 0.51 USD | 0.2719 USD | +87.6% | Beat |
| 2025-05-01 | 0.11 USD | 0.09324 USD | +18% | Beat |
| 2025-02-20 | 0.26 USD | 0.1628 USD | +59.7% | Beat |
| 2024-11-07 | -0.01 USD | 0.1368 USD | -107.3% | Miss |
| 2024-07-31 | 0.1 USD | 0.1301 USD | -23.1% | Miss |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
CCJ valuation and analyst view
| Trailing P/E | 84.89 |
|---|---|
| Trailing EPS | 1.494 USD |
| Price / book | 7.85 |
| Dividend yield | 0.19% |
| Market cap | 39.68B |
| Analyst consensus | Buy (13 buy / 5 hold / 2 sell) |
| Avg price target | 130.2 USD |
Related research pages
Frequently asked questions
When is Cameco (CCJ)'s next earnings date?
Cameco is next scheduled to report on 2026-07-31, with a consensus EPS estimate of 0.31 USD and revenue estimate of 0.57B.
Did CCJ beat earnings last quarter?
In its 2026-02-13 report, CCJ posted EPS of 0.36 USD versus a 0.29 USD estimate — a beat of 24.1%.
What is CCJ's earnings track record?
Over the last 6 reported quarters with consensus data, CCJ beat estimates 4 times (67%).
What is CCJ's current P/E ratio and EPS?
CCJ trades at a trailing P/E of 84.89 on trailing EPS of 1.493732908715608 USD.
What do analysts rate CCJ?
Analyst consensus is "Buy" across 20 ratings (1 strong buy, 12 buy, 5 hold, 2 sell, 0 strong sell). Average 12-month price target: 130.2 USD.